Classification of nanomaterials

JRC and partners of EU project NanoDefine develop strategy for identifying nanomaterials based on particles’ volume specific surface area (VSSA)

Regulation of nanomaterials in the EU

JRC study reviews EU legislation on nanomaterials; summarizes different sectors with nano-specific provisions, such as plastic FCM regulation; more research needed to address regulatory questions

Member States continue discussion on EDC criteria

DG SANTE publishes latest meeting minutes on revised EDC criteria; no agreement yet among Member States

Temporary approach for migration of biocides

EU competent authorities for biocides decide on interim approach to set residue and migration limits for active substances in food-related products and food contact materials

Conference report: Towards a non-toxic future

Stakeholder conference held by Danish Ministry delivers recommendations for future EU chemicals regulation; conference report now available

EFSA: 4th FIP network meeting on FCMs

EFSA’s Food Ingredients and Packaging Scientific Network held fourth meeting on food contact materials on February 16, 2017; discussions focused on coatings; interest group on evaluation of coatings formed

Vote on EDC criteria again postponed

EU Commission’s PAFF Committee discusses EDC criteria but refrains from vote; Member States still in disagreement over Commission’s latest proposal; no new meeting scheduled yet

EU working group on FCMs: New meeting minutes

EU Commission’s working group on FCMs discusses ex-post evaluation of FCM framework regulation, supply chain survey, EU measure on printed FCMs, plastic recycling, and monitoring of mineral oils in food and FCMs

EU technical expert group for FCMs: Latest meeting minutes

DG SANTE’s technical expert group for FCMs discusses plastic recycling, ex-post evaluation of FCM framework regulation, supply chain survey, and EU measure on printed FCMs

Four phthalates recognized as hormone disrupting for humans

EU REACH Committee classifies DEHP, DBP, BBP, and DIBP as substances of very high concern due to their endocrine disrupting effects in humans